Wiley Michael J 4

4 · Guardant Health, Inc. · Filed Apr 30, 2020

Form 4

Period: 2020-04-28

Chief Legal Officer

Transactions

Exercise/Conversion
COMMON STOCK
2020-04-28$4.18/sh+1,220$5,100→ 112,391 total
Sale
COMMON STOCK
2020-04-28$80.02/sh−1,220$97,628→ 111,171 total
Exercise/Conversion
COMMON STOCK
2020-04-29$4.18/sh+3,780$15,800→ 114,951 total
Sale
COMMON STOCK
2020-04-29$80.11/sh−3,780$302,800→ 111,171 total
Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2020-04-28−1,220→ 44,413 total
Exercise: $4.18Exp: 2027-07-13→ COMMON STOCK (1,220 underlying)
Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2020-04-29−3,780→ 40,633 total
Exercise: $4.18Exp: 2027-07-13→ COMMON STOCK (3,780 underlying)

Footnotes (4)

[F1]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
[F2]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $80.00 to $80.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $80.00 to $80.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
[F4]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.

Documents

1 file